Solid Tumors Clinical Trials

A listing of 48 Solid Tumors clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Solid Tumors

1 - 12 of 48

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 48 active clinical trials seeking participants for Solid Tumors research studies. The states with the highest number of trials for Solid Tumors participants are Texas, California, New York and Tennessee.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Irritability Associated with Autism (Children and Adolescents) Study

Recruiting

Join a clinical trial today and take a step toward finding a better solution for you. Earn money for your time and no-cost medical treatment is provided.

Learn More

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423

Recruiting

The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.

Gender:

All

Ages:

Between 1 month and 17 years

Trial Updated:

05/15/2024

Locations: New York Medical College, Valhalla, New York +3 locations

Conditions: Solid Tumors, Lymphoma

Learn More ›

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

NCT06082960

Recruiting

The main goal of this first in human (FIH) study is to learn about the safety and dosing of GS-9911 when given alone or in combination with an anti-programmed cell death protein 1 (PD-1) monoclonal antibody in participants with advanced solid tumors. The primary objectives of this study are to: Assess the safety and tolerability of GS-9911 as monotherapy and in combination with an anti-PD-1 monoclonal antibody in participants with advanced solid tumors Identify the maximum tolerated dose (MTD)... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

05/14/2024

Locations: Smilow Cancer Hospital Phase 1 Unit, New Haven, Connecticut +5 locations

Conditions: Solid Tumors

Learn More ›

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

NCT04140500

Recruiting

This is a first-in-human, open-label, multicenter, Phase I multiple-ascending dose (MAD) study of RO7247669, an anti PD-1 (programmed death-1) and LAG-3 (Lymphocyte-activation gene 3) bispecific antibody, for participants with advanced and/or metastatic solid tumors. This study aims to establish the maximum tolerated dose (MTD) and/or define the recommended phase 2 dose (RP2D) based on the safety, tolerability, pharmacokinetic (PK) and/or pharmacodynamic (PD) profile of RO7247669, and to evaluat... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

05/13/2024

Locations: Sharp Memorial Hospital, San Diego, California +32 locations

Sharp Memorial Hospital, San Diego, California

Henry Ford Hospital; Hematology/Oncology Phase 1, Detroit, Michigan

Hospital de Clinicas de Porto Alegre X; Centro de Pesquisa Clinica, Porto Alegre, RS

Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, SP

Rigshospitalet; Fase 1 Enhed - Onkologi, København Ø, Not set

Odense Universitetshospital, Onkologisk Afdeling R, Odense C, Not set

LLC Arensia Explorer Medicine, Tbilisi, Not set

Hadassah University Hospital - Ein Kerem; Oncology, Jerusalem, Not set

Rabin MC; Davidof Center - Oncology Institute, Petach Tikva, Not set

Chaim Sheba medical center, Oncology division, Ramat Gan, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco

Inst. Nacional de Cancerología; Pneumology, Mexico City, Mexico CITY (federal District)

Consultorio Médico Jordi Guzmán Casta, Querétaro, Queretaro

The Institute of Oncology, ARENSIA Exploratory Medicine, Chisinau, Not set

IPO do Porto; Servico de Oncologia Medica, Porto, Not set

National University Hospital; National University Cancer Institute, Singapore (NCIS), Singapore, Not set

National Cancer Centre; Medical Oncology, Singapore, Not set

Clinica Universitaria de Navarra; Servicio de Oncologia, Pamplona, Navarra

Hospital del Mar; Servicio de Oncologia, Barcelona, Not set

Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Not set

Clinica Universidad de Navarra Madrid; Servicio de Oncología, Madrid, Not set

START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, Not set

START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid, Not set

Adana City Hospital, Medical Oncology, Adana, Not set

Ankara City Hospital; Oncology, Ankara, Not set

Koc University Hospital; Oncology, Istanbul, Not set

Hacettepe Uni Medical Faculty Hospital; Oncology Dept, Sihhiye/Ankara, Not set

Queen Elizabeth Hospital, Birmingham, Not set

Christie Hospital NHS Trust; Experimental Cancer Medicine Team, Manchester, Not set

Conditions: Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma

Learn More ›

A Study to Test Different Doses of BI 1831169 Alone and in Combination With Ezabenlimab in People With Different Types of Advanced Cancer (Solid Tumors)

NCT05155332

Recruiting

This study is open to adults with different types of advanced cancer (solid tumours) that are accessible for injection. People for whom previous treatment was not successful or for whom no other treatment options exist can join the study. The study tests a medicine called BI 1831169 alone and in combination with another medicine called ezabenlimab. BI 1831169 and ezabenlimab may help the immune system fight cancer. In this study, BI 1831169 is given to people for the first time. The study has... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

05/13/2024

Locations: Providence St. John's Health Center, Santa Monica, California +14 locations

Conditions: Solid Tumors

Learn More ›

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873

Recruiting

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study. This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-up Phase or 3) Second Course Phase. Each participant will transition to this extension study in one of the following three phases, depending on the study phase they were in at the completion of the par... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

05/09/2024

Locations: University of Arizona Cancer Center ( Site 0018), Tucson, Arizona +533 locations

University of Arizona Cancer Center ( Site 0018), Tucson, Arizona

Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054), Bakersfield, California

California Cancer Associates for Research & Excellence ( Site 0016), Fresno, California

The Angeles Clinic and Research Institute ( Site 0005), Los Angeles, California

UCLA Hematology/Oncology - Westwood (Building 100) ( Site 0009), Los Angeles, California

UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0004), San Francisco, California

Providence Saint John's Health Center ( Site 0059), Santa Monica, California

University of Colorado Cancer Center ( Site 0021), Aurora, Colorado

Yale Cancer Center ( Site 0014), New Haven, Connecticut

Georgetown University Medical Center ( Site 0023), Washington, District of Columbia

Holy Cross Hospital, Michael & Dianne Bienes Comp Cancer Ctr ( Site 0022), Fort Lauderdale, Florida

Mount Sinai Medical Center Comprehensive Cancer Center ( Site 0031), Miami Beach, Florida

Moffitt Cancer Center ( Site 0011), Tampa, Florida

Emory School of Medicine ( Site 0013), Atlanta, Georgia

Northwest Georgia Oncology Centers PC ( Site 0061), Marietta, Georgia

Kaiser Permanente Moanalua Medical Center ( Site 0063), Honolulu, Hawaii

The University of Chicago ( Site 0020), Chicago, Illinois

University of Iowa Hospital and Clinics ( Site 0026), Iowa City, Iowa

James Graham Brown Cancer Center ( Site 0058), Louisville, Kentucky

MedStar Franklin Square Medical Center ( Site 0046), Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore, Maryland

Massachusetts General Hospital ( Site 0041), Boston, Massachusetts

Dana-Farber Cancer Institute ( Site 0006), Boston, Massachusetts

Karmanos Cancer Institute ( Site 0047), Detroit, Michigan

Mayo Clinic in Rochester, Minnesota ( Site 0002), Rochester, Minnesota

Comprehensive Cancer Centers of Nevada ( Site 0043), Las Vegas, Nevada

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0038), Hackensack, New Jersey

Cancer Institute of New Jersey ( Site 0025), New Brunswick, New Jersey

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032), New York, New York

Memorial Sloan Kettering Cancer Center ( Site 0012), New York, New York

White Plains Hospital-Center for Cancer Care ( Site 0069), White Plains, New York

WakeMed Cancer Care - Waverly Hematology & Medical Oncology ( Site 0074), Cary, North Carolina

University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill, North Carolina

Levine Cancer Institute ( Site 0034), Charlotte, North Carolina

Duke Cancer Center ( Site 0028), Durham, North Carolina

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0065), Fargo, North Dakota

University Hospitals ( Site 0044), Cleveland, Ohio

Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082), Tulsa, Oklahoma

Providence Portland Medical Center ( Site 0051), Portland, Oregon

St. Luke's University Health Network ( Site 0017), Bethlehem, Pennsylvania

University of Pennsylvania ( Site 0010), Philadelphia, Pennsylvania

Fox Chase Cancer Center ( Site 0042), Philadelphia, Pennsylvania

UPMC Hillman Cancer Center ( Site 0008), Pittsburgh, Pennsylvania

Sanford Cancer Center ( Site 0066), Sioux Falls, South Dakota

West Cancer Center and Research Institute ( Site 0055), Germantown, Tennessee

Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville, Tennessee

Vanderbilt Ingram Cancer Center ( Site 0015), Nashville, Tennessee

Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas, Texas

University of Texas MD Anderson Cancer Center ( Site 0007), Houston, Texas

South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001), San Antonio, Texas

University of Virginia Health System ( Site 0035), Charlottesville, Virginia

Bon Secours St. Francis Medical Center-Oncology Research ( Site 0075), Midlothian, Virginia

Blue Ridge Cancer Care ( Site 0067), Roanoke, Virginia

Seattle Cancer Care Alliance ( Site 0024), Seattle, Washington

Hospital Aleman-Oncology ( Site 1351), Buenos Aires, Caba

Clinica Viedma ( Site 1353), Viedma, Rio Negro

Sanatorio Parque ( Site 1355), Rosario, Santa Fe

Instituto de Oncologia de Rosario ( Site 1350), Rosario, Santa Fe

Hospital Privado Universitario de Córdoba ( Site 1354), Cordoba, Not set

Fundación CORI para la Investigación y Prevención del Cáncer ( Site 1358), La Rioja, Not set

Centro Medico San Roque-Oncology ( Site 1352), Tucuman, Not set

Chris OBrien Lifehouse ( Site 3003), Camperdown, New South Wales

Royal Prince Alfred Hospital-A.W. Morrow Gastroenterology and Liver Centre ( Site 3016), Camperdown, New South Wales

Liverpool Hospital-Medical Oncology ( Site 3021), Liverpool, New South Wales

Macquarie University ( Site 3010), Macquarie University, New South Wales

Mater Hospital Sydney ( Site 3007), North Sydney, New South Wales

Orange Hospital-Clinical Trials Unit ( Site 3027), Orange, New South Wales

Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3020), Port Macquarie, New South Wales

Royal North Shore Hospital-Medical Oncology Clinical Trials ( Site 3025), St Leonards, New South Wales

Calvary Mater Newcastle ( Site 3005), Waratah, New South Wales

Westmead Hospital ( Site 3000), Westmead, New South Wales

Melanoma Institute Australia ( Site 3001), Wollstonecraft, New South Wales

Mater Misericordiae Limited-Medical Oncology ( Site 3019), Brisbane, Queensland

Gallipoli Medical Research Ltd ( Site 3011), Brisbane, Queensland

Royal Brisbane and Women s Hospital ( Site 3009), Herston, Queensland

Tasman Oncology Research Pty Ltd ( Site 3012), Southport, Queensland

The Townsville Hospital ( Site 3017), Townsville, Queensland

Princess Alexandra Hospital ( Site 3002), Woolloongabba, Queensland

Royal Adelaide Hospital ( Site 3014), Adelaide, South Australia

The Queen Elizabeth Hospital ( Site 3026), Woodville, South Australia

Monash Health ( Site 3015), Clayton, Victoria

Austin Health-Austin Hospital ( Site 3004), Heidelberg, Victoria

Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 3008), Melbourne, Victoria

St Vincent's Hospital-Oncology Clinical Trials ( Site 3018), Melbourne, Victoria

Western Health-Sunshine & Footscray Hospitals ( Site 3023), St Albans, Victoria

Ballarat Oncology & Haematology Services ( Site 3022), Wendouree, Victoria

Sir Charles Gairdner Hospital ( Site 3006), Nedlands, Western Australia

St John of God Subiaco Hospital ( Site 3013), Subiaco, Western Australia

Kepler Universitätsklinikum ( Site 2955), Linz, Oberosterreich

Medical University of Graz ( Site 2952), Graz, Steiermark

Medizinische Universitaet Innsbruck ( Site 2951), Innsbruck, Tirol

Uniklinikum Salzburg ( Site 2956), Salzburg, Not set

Medizinische Universität Wien ( Site 2953), Wien, Not set

Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2954), Wien, Not set

AZ Sint-Maarten ( Site 2904), Mechelen, Antwerpen

Institut Jules Bordet ( Site 2903), Anderlecht, Bruxelles-Capitale, Region De

UZ Brussel ( Site 2900), Brussels, Bruxelles-Capitale, Region De

Cliniques Universitaires de Bruxelles - CUB - Hopital Erasme ( Site 2905), Bruxelles, Bruxelles-Capitale, Region De

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi, Yvoir, Namur

AZ Maria Middelares ( Site 2908), Gent, Oost-Vlaanderen

UZ Leuven ( Site 2901), Leuven, Vlaams-Brabant

UZ Leuven - Campus Gasthuisberg ( Site 2906), Leuven, Vlaams-Brabant

UZ Leuven Gasthuisberg, Gynaecologie-Verloskunde ( Site 2907), Leuven, Vlaams-Brabant

CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 1024), Fortaleza, Ceara

ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 1008), Ijui, Rio Grande Do Sul

Hospital de Clinicas de Porto Alegre ( Site 1000), Porto Alegre, Rio Grande Do Sul

Hospital São Lucas da PUCRS-Centro de Pesquisa em Oncologia ( Site 1006), Porto Alegre, Rio Grande Do Sul

Hospital Nossa Senhora da Conceição ( Site 1011), Porto Alegre, Rio Grande Do Sul

Clinica Viver ( Site 1021), Santa Maria, Rio Grande Do Sul

CEPON ( Site 1012), Florianópolis, Santa Catarina

Fundação Pio XII - Hospital de Câncer de Barretos ( Site 1010), Barretos, Sao Paulo

Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site, São José do Rio Preto, Sao Paulo

Clínica de Pesquisa e Centro de Estudos em Ginecologia Oncológica e Mamária LTDA ( Site 1017), São Paulo, Sao Paulo

Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA ( Site 1020), Rio de Janeiro, Not set

Instituto de de Educação, pesquisa e Gestão em Saúde ( Site 1014), Rio de Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 1001), Sao Paulo, Not set

A. C. Camargo Cancer Center ( Site 1002), Sao Paulo, Not set

Cross Cancer Institute ( Site 2804), Edmonton, Alberta

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2801), Hamilton, Ontario

Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2808), Kingston, Ontario

London Regional Cancer Program - LHSC ( Site 2806), London, Ontario

Sunnybrook Research Institute ( Site 2802), Toronto, Ontario

Mount Sinai Hospital ( Site 2811), Toronto, Ontario

Princess Margaret Cancer Centre ( Site 2803), Toronto, Ontario

Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre-Oncology ( Site 2809), Greenfield Park, Quebec

Centre Intégré de Santé et de Services Sociaux (CISSS) de La-Centre intégré de cancérologie de Lava, Laval, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 2807), Montreal, Quebec

Jewish General Hospital ( Site 2800), Montreal, Quebec

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 2, Quebec, Not set

James Lind Centro de Investigación del Cáncer ( Site 2757), Temuco, Araucania

Orlandi Oncologia-Oncology ( Site 2752), Santiago, Region M. De Santiago

Fundacion Arturo Lopez Perez FALP ( Site 2750), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 2751), Santiago, Region M. De Santiago

Instituto Nacional del Cancer-CR Investigación ( Site 2753), Santiago, Region M. De Santiago

Bradfordhill-Clinical Area ( Site 2756), Santiago, Region M. De Santiago

Centro de Investigaciones ( Site 2755), Viña del Mar, Valparaiso

Anhui Provincial Hospital-Cancer Chemotherapy Department ( Site 3480), Hefei, Anhui

Anhui Provincil Hospital South District-Respiratory Medicine Dept ( Site 3487), Hefei, Anhui

Beijing Cancer Hospital ( Site 3451), Beijing, Beijing

Affiliated Hospital of Military Medical Science Academy of the PLA ( Site 3465), Beijing, Beijing

Beijing Cancer hospital-Thoracic Cancer Department A ( Site 3454), Beijing, Beijing

Beijing Peking Union Medical College Hospital-Medical Oncology ( Site 3466), Beijing, Beijing

Army Medical Center of People's Liberation Army-Oncology Department ( Site 3477), Chongqing, Chongqing

Fujian Provincial Cancer Hospital ( Site 3461), Fuzhou, Fujian

SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal Medicine ( Site 3452), Guangzhou, Guangdong

Sun Yat-sen University Cancer Center-melanoma ( Site 3482), Guangzhou, Guangdong

Guangdong Provincial People's Hospital-Cancer Center ( Site 3462), Guangzhou, Guangdong

The First Affiliated Hospital, Sun Yat-sen University-pneumology department ( Site 3459), Guangzhou, Guangdong

The First Affiliated Hospital of Guangzhou Medical University-thoracic surgery department ( Site 346, Guangzhou, Guangdong

Harbin Medical University Cancer Hospital-Harbin Medical University Cancer Hospital ( Site 3475), Harbin, Heilongjiang

Tongji Hospital Tongji Medical,Science & Technology-oncology ( Site 3476), Wuhan, Hubei

Xiangya Hospital Central South University-Respiratory ( Site 3479), Changsha, Hunan

Hunan Cancer Hospital ( Site 3485), Changsha, Hunan

Jiangsu Cancer Hospital-Medical Oncotherapy ( Site 3469), Nanjing, Jiangsu

Northern Jiangsu People's Hospital-General Surgery Department ( Site 3474), Yangzhou, Jiangsu

The First Hospital of Jilin University-Oncology ( Site 3464), Changchun, Jilin

Jilin Province Tumor Hospital ( Site 3484), Changchun, Jilin

Tangdu Hospital of Fourth Military Medical University of Chi-department of radiotherapy ( Site 3455), Xi'an, Shaanxi

Fudan University Shanghai Cancer Center ( Site 3467), Shanghai, Shanghai

Shanghai Pulmonary Hospital ( Site 3470), Shanghai, Shanghai

West China Hospital Sichuan University-respiratory ( Site 3473), Cheng Du, Sichuan

Tianjin Medical University Cancer Institute and Hospital ( Site 3456), Tianjin, Tianjin

Hangzhou Cancer Hospital-Medical Oncology ( Site 3468), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 3481), Hangzhou, Zhejiang

Instituto de Cancerología-Oncology ( Site 2702), Medellín, Antioquia

Oncomédica S.A.S ( Site 2703), Montería, Cordoba

Administradora Country S.A. ( Site 2701), Bogota, Distrito Capital De Bogota

Fundación Valle del Lili ( Site 2700), Cali, Valle Del Cauca

Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0703), Brno, Brno-mesto

Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0704), Olomouc, Olomoucky Kraj

Fakultni Thomayerova nemocnice-Onkologicka klinika 1. LF UK ( Site 0702), Prague, Praha 4

Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0705), Praha, Praha 5

Fakultni nemocnice Olomouc ( Site 0701), Olomouc, Not set

Fakultni nemocnice v Motole ( Site 0700), Praha 5, Not set

Odense Universitetshospital ( Site 0650), Odense, Syddanmark

Vejle Sygehus ( Site 0653), Vejle, Syddanmark

Tartu University Hospital-Radiotherapy and oncology ( Site 3800), Tartu, Tartumaa

Tampere University Hospital [Tampere Finland] ( Site 0600), Tampere, Pirkanmaa

Turku University Hospital ( Site 0601), Turku, Varsinais-Suomi

Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Dermatology Department ( Site 2539), Nice, Alpes-Maritimes

Nouvel Hôpital Civil (NHC) ( Site 2529), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque ( Site 2534), Pessac, Aquitaine

Centre Hopitalar Leon-Berard ( Site 2519), Lyon, Auvergne

Hopital Nord ( Site 2516), Marseille, Bouches-du-Rhone

CHU La Timone ( Site 2508), Marseille, Bouches-du-Rhone

Centre Georges François Leclerc-Centre de recherche clinique ( Site 2536), Dijon, Cote-d Or

CHU Jean Minjoz ( Site 2520), Besancon, Doubs

CHU de Brest -Site Hopital Morvan ( Site 2504), Brest, Finistere

Institut Bergonie ( Site 2502), Bordeaux, Gironde

CHU de Toulouse - Hopital Larrey-service de pneumologie ( Site 2526), Toulouse, Haute-Garonne

CHU Toulouse - Hopital Rangueil ( Site 2518), Toulouse, Haute-Garonne

Ambroise Pare Hopital ( Site 2503), Boulogne, Hauts-de-Seine

Hôpital Beaujon ( Site 2524), Clichy, Ile-de-France

Groupe hospitalier Paris saint Joseph-Service de Pneumologie-Allergologie -Oncologie Thoracique ( Si, Paris, Ile-de-France

Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 2525), Rennes, Ille-et-Vilaine

Hopital Trousseau ( Site 2512), Chambray-les-Tours, Indre-et-Loire

C.H.U. de Tours - Hopital Bretonneau ( Site 2515), Tours, Indre-et-Loire

Institut de Cancérologie de l'Ouest-Oncologie Médicale ( Site 2522), Saint Herblain, Loire-Atlantique

Institut de Cancérologie de Lorraine Alexis Vautrin ( Site 2532), Vandoeuvre-lès-Nancy, Lorraine

CHRU Lille Hospital Claude Huriez ( Site 2506), Lille, Nord

Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 2542), Clermont-Ferrand, Puy-de-Dome

CH Lyon Sud Hospices Civils de Lyon ( Site 2521), Pierre Benite, Rhone-Alpes

C.H.U. Pontchaillou ( Site 2511), Pierre Benite, Rhone

Centre Hospitalier du Mans-Pneumologie ( Site 2527), Le Mans, Sarthe

Hôpital Avicenne-Dermatologie ( Site 2538), Bobigny, Seine-Saint-Denis

Centre Hopitalier Intercommunal Creteil ( Site 2514), Creteil, Val-de-Marne

Hôpital Universitaire Paul Brousse ( Site 2541), Villejuif, Val-de-Marne

Institut Gustave Roussy ( Site 2513), Villejuif, Val-de-Marne

Hopital Cochin ( Site 2509), Paris, Not set

Hopital Saint Louis ( Site 2510), Paris, Not set

CHU Hopital Saint Antoine ( Site 2517), Paris, Not set

Hôpital Tenon ( Site 2530), Paris, Not set

Universitaetsklinikum Tuebingen ( Site 2405), Tuebingen, Baden-Wurttemberg

Universitätsklinikum Erlangen ( Site 2408), Erlangen, Bayern

Universitaetsklinik Muenchen ( Site 2406), Muenchen, Bayern

Krankenhaus Nordwest ( Site 2409), Frankfurt, Hessen

Elbe Klinikum Buxtehude ( Site 2400), Buxtehude, Niedersachsen

Medizinische Hochschule Hannover ( Site 2402), Hannover, Niedersachsen

Universitaetsklinikum Essen ( Site 2404), Essen, Nordrhein-Westfalen

Universitaetsklinikum des Saarlandes-Klinik für Innere Medizin V-Pneumologie, Allergologie, Beatmun, Homburg, Saarland

Universitatsklinikum Carl Gustav Carus ( Site 2407), Dresden, Sachsen

LungenClinic Grosshansdorf GmbH ( Site 2412), Grosshansdorf, Schleswig-Holstein

SRH Wald-Klinikum Gera GmbH ( Site 2403), Gera, Thuringen

Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 2418), Berlin, Not set

Facharztzentrum Eppendorf ( Site 2415), Hamburg, Not set

General Hospital of Athens "Laiko"-Hematology Department ( Site 1851), Athens, Attiki

Sotiria Regional Chest Diseases Hospital of Athens ( Site 1850), Athens, Attiki

Oncomedica ( Site 3401), Guatemala, Not set

Grupo Medico Angeles ( Site 3402), Guatemala, Not set

MEDI-K CAYALA ( Site 3403), Guatemala, Not set

Queen Mary Hospital ( Site 1902), Hksar, Not set

Queen Mary Hospital-Department of Medicine (Respiratory) ( Site 1900), Hksar, Not set

Békés Megyei Központi Kórház Pándy Kálmán Tagkórház-Megyei Onkológiai Centrum ( Site 1405), Gyula, Bekes

Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház ( Site 1409), Miskolc, Borsod-Abauj-Zemplen

Fejér Megyei Szent György Egyetemi Oktató Kórház-l.Pulmonologia ( Site 1407), Székesfehérvár, Fejer

Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 1401), Szolnok, Jasz-Nagykun-Szolnok

Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 1411), Budapest, Pest

Markusovszky Egyetemi Oktatokorhaz-Onkológiai Osztály ( Site 1410), Szombathely, Vas

Farkasgyepui Tudogyogyintezet-Pulmonologia ( Site 1414), Farkasgyepu, Veszprem

Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 1406), Budapest, Not set

Orszagos Koranyi Pulmonologiai Intezet ( Site 1403), Budapest, Not set

Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 1413), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Haematologia) ( Site 1415), Debrecen, Not set

Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 1412), Debrecen, Not set

Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1402), Kaposvar, Not set

Zala Megyei Szent Rafael Korhaz ( Site 1400), Zalaegerszeg, Not set

Mater Misercordiae University Hospital ( Site 1800), Dublin, Leinster

Tallaght University Hospital ( Site 1803), Dublin, Not set

St. James s Hospital ( Site 1801), Dublin, Not set

Rambam Health Care Campus-Oncology Division ( Site 2053), Haifa, Not set

Hadassah Ein Kerem Medical Center ( Site 2051), Jerusalem, Not set

Rabin Medical Center ( Site 2059), Petah-Tikva, Not set

Chaim Sheba Medical Center ( Site 2055), Ramat Gan, Not set

Chaim Sheba Medical Center. ( Site 2052), Ramat Gan, Not set

Sourasky Medical Center ( Site 2054), Tel Aviv, Not set

Shamir Medical Center Assaf Harofeh ( Site 2058), Zerifin, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1975), Roma, Lazio

Policlinico Universitario Agostino Gemelli ( Site 1965), Roma, Lazio

Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1968), Rozzano, Milano

Ospedale San Luigi Gonzaga ( Site 1956), Orbassano, Piemonte

IRCCS CRO Aviano, Hematology/Oncology ( Site 1957), Aviano, Pordenone

Istituto di Candiolo - IRCCS ( Site 1960), Candiolo, Torino

AO Santa Maria della Misericordia-Oncology Department ( Site 1971), Perugia, Umbria

Humanitas Gavazzeni ( Site 1954), Bergamo, Not set

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII-UOC Oncologia ( Site 1967), Bergamo, Not set

Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 1972), Brescia, Not set

IRCCS A.O.U. San Martino - IST ( Site 1961), Genova, Not set

Istituto Europeo di Oncologia ( Site 1952), Milano, Not set

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1955), Napoli, Not set

Azienda Ospedaliero Universitaria di Parma-UO Oncologia Medica ( Site 1964), Parma, Not set

Azienda Ospedaliera San Camillo Forlanini ( Site 1958), Roma, Not set

ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 1969), Siena, Not set

Azienda Ospedaliera Santa Maria ( Site 1962), Terni, Not set

Nagoya University Hospital ( Site 3151), Nagoya-Shi, Aichi

National Hospital Organization Nagoya Medical Center ( Site 3109), Nagoya, Aichi

Aichi Cancer Center Hospital ( Site 3101), Nagoya, Aichi

National Cancer Center Hospital East ( Site 3121), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 3116), Matsuyama, Ehime

Kurume University Hospital ( Site 3105), Kurume, Fukuoka

National Hospital Organization Hokkaido Cancer Center ( Site 3160), Sapporo, Hokkaido

Sapporo Kosei General Hospital ( Site 3172), Sapporo, Hokkaido

Sapporo Medical University Hospital ( Site 3113), Sapporo, Hokkaido

Hokkaido University Hospital ( Site 3165), Sapporo, Hokkaido

Hyogo Cancer Center ( Site 3131), Akashi, Hyogo

National Hospital Organization Himeji Medical Center ( Site 3111), Himeji, Hyogo

Kobe City Medical Center General Hospital ( Site 3144), Kobe, Hyogo

Hyogo Medical University Hospital ( Site 3100), Nishinomiya, Hyogo

Kanazawa University Hospital ( Site 3140), Kanazawa, Ishikawa

Kagawa University Hospital ( Site 3171), Kita, Kagawa

Kitasato University Hospital ( Site 3142), Sagamihara, Kanagawa

Yokohama City University Hospital ( Site 3163), Yokohama, Kanagawa

Kanagawa cancer center ( Site 3137), Yokohama, Kanagawa

Yokosukakyosai ( Site 3150), Yokosuka, Kanagawa

Miyagi Cancer Center ( Site 3122), Natori, Miyagi

Sendai Kousei Hospital ( Site 3115), Sendai, Miyagi

Nara Medical University Hospital ( Site 3110), Kashihara, Nara

Kurashiki Central Hospital ( Site 3132), Kurashiki, Okayama

University of the Ryukyus Hospital ( Site 3155), Nishihara, Okinawa

Osaka Habikino Medical Center ( Site 3138), Habikino, Osaka

Kansai Medical University Hospital ( Site 3126), Hirakata, Osaka

Kindai University Hospital- Osakasayama Campus ( Site 3166), Osaka-sayama, Osaka

Kindai University Hospital ( Site 3102), Osakasayama, Osaka

Kindai University Hospital- Osakasayama Campus-Department of Gastroenterology and Hepatology ( Site, Osakasayama, Osaka

Osaka Rosai Hospital ( Site 3148), Sakai, Osaka

Osaka University Hospital ( Site 3168), Suita, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3167), Takatsuki, Osaka

Saitama Medical University International Medical Center ( Site 3118), Hidaka, Saitama

Saitama Cancer Center ( Site 3112), Kitaadachi-gun, Saitama

Dokkyo Medical University - Koshigaya Hospital ( Site 3152), Koshigaya, Saitama

Shizuoka Cancer Center ( Site 3128), Nagaizumi, Shizuoka

Jichi Medical University Hospital ( Site 3141), Shimotsuke, Tochigi

Tokyo Medical and Dental University Hospital ( Site 3149), Bunkyō, Tokyo

Japanese Foundation for Cancer Research ( Site 3146), Koto, Tokyo

Japanese Foundation for Cancer Research ( Site 3164), Koto, Tokyo

Toranomon Hospital ( Site 3134), Minato-ku, Tokyo

Toranomon Hospital ( Site 3153), Minato-ku, Tokyo

Kyorin University Hospital ( Site 3147), Mitaka-shi, Tokyo

Kyorin University Hospital ( Site 3103), Mitaka, Tokyo

Tokyo Medical University Hospital ( Site 3170), Shinjuku-ku, Tokyo

National Hospital Organization Yamaguchi Ube Medical Center ( Site 3123), Ube, Yamaguchi

Yamaguchi University Hospital ( Site 3114), Ube, Yamaguchi

Chiba Cancer Center ( Site 3117), Chiba, Not set

National Hospital Organization Kyushu Medical Center ( Site 3136), Fukuoka, Not set

National Hospital Organization Kyushu Cancer Center ( Site 3169), Fukuoka, Not set

Kyushu University Hospital ( Site 3143), Fukuoka, Not set

Gifu University Hospital ( Site 3161), Gifu, Not set

Hiroshima City Hiroshima Citizens Hospital ( Site 3119), Hiroshima, Not set

Hiroshima University Hospital ( Site 3154), Hiroshima, Not set

Kochi Health Sciences Center ( Site 3145), Kochi, Not set

Okayama University Hospital ( Site 3107), Okayama, Not set

Osaka City General Hospital ( Site 3125), Osaka, Not set

National Hospital Organization - Osaka National Hospital - Institute For Clinical Research ( Site 31, Osaka, Not set

Osaka International Cancer Institute-Gynecologic Oncology ( Site 3129), Osaka, Not set

National Cancer Center Hospital ( Site 3130), Tokyo, Not set

St.Luke's International Hospital ( Site 3120), Tokyo, Not set

The Jikei University Hospital-Obstetrics and Gynecology ( Site 3156), Tokyo, Not set

Nippon Medical School Hospital ( Site 3139), Tokyo, Not set

Tokyo Metropolitan Komagome Hospital ( Site 3133), Tokyo, Not set

The Cancer Institute Hospital of JFCR ( Site 3108), Tokyo, Not set

Keio University Hospital ( Site 3127), Tokyo, Not set

Teikyo University Hospital ( Site 3104), Tokyo, Not set

Wakayama Medical University Hospital ( Site 3124), Wakayama, Not set

Chonnam National University Hwasun Hospital-Hemato-Oncology ( Site 0959), Hwasun, Jeonranamdo

National Cancer Center ( Site 0955), Goyang-si, Kyonggi-do

CHA Bundang Medical Center CHA University ( Site 0957), Seongnam si, Kyonggi-do

Seoul National University Bundang Hospital ( Site 0951), Seongnam-si, Kyonggi-do

Asan Medical Center ( Site 0952), Songpagu, Seoul

Keimyung University Dongsan Hospital ( Site 0960), Daegu, Taegu-Kwangyokshi

Chungnam national university hospital-Department of Internal Medicine ( Site 0958), Daejeon, Taejon-Kwangyokshi

Korea University Anam Hospital ( Site 0956), Seoul, Not set

Seoul National University Hospital ( Site 0953), Seoul, Not set

Severance Hospital ( Site 0954), Seoul, Not set

Samsung Medical Center ( Site 0950), Seoul, Not set

Liepjas reionl slimnca ( Site 3851), Liepaja, Not set

RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia-Out-patient and Day patient facility of Ch, Riga, Not set

Klaipeda University Hospital-Oncology chemotherapy ( Site 3302), Klaipeda, Klaipedos Miestas

National Cancer Institute-Chemotherapy departament with day care unit ( Site 3301), Vilnius, Vilniaus Miestas

Vilniaus Universiteto Ligonine Santaros Klinikos ( Site 3300), Vilnius, Not set

Hospital Tengku Ampuan Afzan ( Site 0627), Kuantan, Pahang

Gleneagles Penang ( Site 0625), Georgetown, Pulau Pinang

Pantai Hospital Kuala Lumpur ( Site 0628), Kuala Lumpur, Not set

University Malaya Medical Centre ( Site 0626), Kuala Lumpur, Not set

INSTITUTO NACIONAL DE CANCEROLOGIA ( Site 1102), Mexico City, Distrito Federal

Avix Investigación Clinica, S.C.-Oncology ( Site 1104), Monterrey, Nuevo Leon

Oaxaca Site Management Organization ( Site 1106), Oaxaca de Juarez, Oaxaca

Medical Care and Research SA de CV ( Site 1103), Merida, Yucatan

Oncare Viaducto Napoles ( Site 1107), Cdmx, Not set

Radboud University Medical Center ( Site 1554), Nijmegen, Gelderland

Antoni van Leeuwenhoek Ziekenhuis ( Site 1551), Amsterdam, Noord-Holland

Amsterdam UMC, locatie VUmc ( Site 1555), Amsterdam, Noord-Holland

Erasmus MC ( Site 1553), Rotterdam, Zuid-Holland

Universitair Medisch Centrum Groningen ( Site 1550), Groningen, Not set

Canterbury Regional Cancer & Blood Service ( Site 1500), Christchurch, Canterbury

Waikato Hospital ( Site 1502), Hamilton, Waikato

Auckland City Hospital ( Site 1503), Auckland, Not set

Capital & Coast District Health Board - Wellington Hospital ( Site 1501), Wellington, Not set

Helse Bergen Haukeland universitetssykehus ( Site 1451), Bergen, Vestfold

Oslo Universitetssykehus Radiumhospitalet ( Site 1450), Oslo, Not set

Oslo Universitetssykehus Ullevål-Avdeling for kreftbehandling, Ullevål ( Site 1452), Oslo, Not set

Hospital Cayetano Heredia-Oncology ( Site 0675), Lima, Not set

Makati Medical Center ( Site 1702), Makati, National Capital Region

Lung Center of the Philippines ( Site 1705), Quezon City, National Capital Region

St. Luke s Medical Center ( Site 1700), Quezon City, National Capital Region

Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1612), Bydgoszcz, Kujawsko-pomorskie

Powiatowe Centrum Zdrowia w Brzezinach Sp. z o. o. Oddział Dziennej Chemioterapii ( Site 1611), Brzeziny, Lodzkie

Instytut Centrum Zdrowia Matki Polki-Klinika Onkologii ( Site 1609), Łódź, Lodzkie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 1608), Krakow, Malopolskie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Wojskowy Instytut Medyczny-Klinika Onkologii ( Site 1606), Warszawa, Mazowieckie

Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Kosza-Klinika Onkologii z Odcinkiem Dziennym, Opole, Opolskie

Bialostockie Centrum Onkologii ( Site 1610), Bialystok, Podlaskie

Przychodnia Lekarska KOMED ( Site 1603), Konin, Wielkopolskie

Med-Polonia Sp. z o. o. ( Site 1605), Poznan, Wielkopolskie

Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna, Poznan, Wielkopolskie

Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1614), Koszalin, Zachodniopomorskie

Champalimaud Foundation ( Site 1751), Lisbon, Lisboa

Centro Hospitalar Lisboa Norte E.P.E. - Hospital Pulido Valente ( Site 1750), Lisboa, Not set

Instituto Português de Oncologia do Porto Francisco Gentil, EPE-Oncologia Médica ( Site 1753), Porto, Not set

Centro Hospitalar de Sao Joao - Hospital de Sao Joao ( Site 1752), Porto, Not set

Ad-Vance Medical Research-Research ( Site 1151), Ponce, Not set

FDI Clinical Research ( Site 1152), San Juan, Not set

UPR Comprehensive Cancer Center ( Site 1150), San Juan, Not set

Spitalul Județean Sfântul Ioan cel Nou Suceava-Oncology ( Site 3550), Suceava, Not set

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1204), Ufa, Baskortostan, Respublika

Bashkir State Medical University ( Site 1221), Ufa, Baskortostan, Respublika

Belgorod Oncology Dispensary ( Site 1213), Belgorod, Belgorodskaya Oblast

Regional Budgetary Healthcare Institution 'Ivanovo Regional Oncology Dispensary'-Urology ( Site 1219, Ivanovo, Ivanovskaya Oblast

GBUZ LOKB ( Site 1218), Saint-Petersburg, Leningradskaya Oblast

GBUZ LOKB-Oncology department #1 ( Site 1222), Saint-Petersburg, Leningradskaya Oblast

Ogarev Mordovia State University ( Site 1206), Saransk, Mordoviya, Respublika

The National Medico-Surgical Center N.I. Pirogov ( Site 1225), Moscow, Moskva

N.N. Blokhin NMRCO ( Site 1209), Moscow, Moskva

Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 1201), Moscow, Moskva

Russian Scientific Center of Roentgenoradiology ( Site 1215), Moscow, Moskva

P. A. Hertsen Moscow Oncology Research Center ( Site 1214), Moscow, Moskva

FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 1208), Moscow, Moskva

Russian Scientific Research Institute of Hematology and Blood Transfusion-Hematology ( Site 1224), Saint Petersburg, Sankt-Peterburg

N.N.Petrov Research Institute of Oncology-Department of Preclinical and Clinical Research ( Site 121, Saint Petersburg, Sankt-Peterburg

Clinical Research Center of specialized types medical care-Oncology ( Site 1205), Saint-Petersburg, Sankt-Peterburg

GBUZ SK Pyatigorsk Interdistrict Oncology dispensary ( Site 1223), Pyatigorsk, Stavropol Skiy Kray

Republican Clinical Oncology Dispensary ( Site 1228), Kazan, Tatarstan, Respublika

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1203), Kazan, Tatarstan, Respublika

Tomsk Scientific Research Institute of Oncology ( Site 1227), Tomsk, Tomskaya Oblast

SAIH of the Tyumen region, Multidisciplinary Clinical Medical Center "Medical town" ( Site 1220), Tyumen, Tyumenskaya Oblast

Udmurtian Republican Clinical Oncology Center ( Site 1212), Izhevsk, Udmurtskaya Respublika

National Cancer Centre Singapore ( Site 2200), Singapore, Central Singapore

National University Hospital-Haematology -Oncology Research Group ( Site 2201), Singapore, South West

Wits Clinical Research ( Site 2002), Johannesburg, Gauteng

Wilgers Oncology Centre ( Site 2006), Pretoria, Gauteng

LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 2005), Pretoria, Gauteng

Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 2004), Sandton, Gauteng

The Oncology Centre ( Site 2000), Durban, Limpopo

Cape Town Oncology Trials ( Site 2007), Cape Town, Western Cape

GVI Oncology ( Site 2008), George, Western Cape

Hospital Universitario Virgen de la Victoria ( Site 0878), Malaga, Andalucia

Hospital Universitario Central de Asturias-Medical Oncology ( Site 0870), Oviedo, Asturias

Hospital Universitari Son Espases-Oncologia ( Site 0883), Palma, Baleares

Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0860), Hospitalet de Llobregat, Barcelona

H. Marques de Valdecilla ( Site 0865), Santander, Cantabria

Hospital Clinic de Barcelona ( Site 0852), Barcelona, Cataluna

Hospital de la Santa Creu i Sant Pau-Oncología Médica ( Site 0862), Barcelona, Cataluna

CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 0876), Santiago de Compostela, La Coruna

Hospital Universitario Insular de Gran Canaria ( Site 0867), Las Palmas de Gran Canaria, Las Palmas

Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 0877), Madrid, Madrid, Comunidad De

Hospital Universitario Puerta de Hierro-Majadahonda ( Site 0861), Majadahonda, Madrid

Hospital Universitario Quiron Madrid ( Site 0868), Pozuelo de Alarcon, Madrid

H.R.U Malaga - Hospital General ( Site 0884), Málaga, Malaga

Hospital Universitari Sant Joan de Reus-Oncology ( Site 0874), Reus, Tarragona

Instituto Valenciano de Oncologia - IVO ( Site 0863), Valencia, Valenciana, Comunitat

Hospital Clinico de Valencia ( Site 0858), Valencia, Valenciana, Comunitat

Hospital General Universitario de Valencia ( Site 0854), Valencia, Valenciana, Comunitat

Hospital Arnau de Vilanova ( Site 0866), Valencia, Valenciana, Comunitat

Hospital Universitari i Politecnic La Fe ( Site 0875), València, Valencia

Hospital General Universitario de Alicante-Oncologia ( Site 0881), Alicante, Not set

Parc de Salut Mar - Hospital del Mar-Oncologia ( Site 0873), Barcelona, Not set

H.U. Vall de Hebron ( Site 0850), Barcelona, Not set

Institut Catala d Oncologia Hospital Germans Trias i Pujol ( Site 0851), Barcelona, Not set

Complejo Hospitalario de Jaén-Servicio de Oncología Médica ( Site 0879), Jaen, Not set

Hospital Universitario Gregorio Maranon ( Site 0864), Madrid, Not set

Clinica Universitaria de Navarra ( Site 0855), Madrid, Not set

Hospital Clinico San Carlos ( Site 0857), Madrid, Not set

Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 0871), Madrid, Not set

Hospital General Universitario 12 de Octubre ( Site 0856), Madrid, Not set

Hospital Universitario La Paz ( Site 0853), Madrid, Not set

Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid, ( Site 0, Madrid, Not set

Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 0880), Sevilla, Not set

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 0872), Sevilla, Not set

Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 0882), Sevilla, Not set

Hospital Clinico Universitario Lozano Blesa ( Site 0859), Zaragoza, Not set

Karolinska Universitetssjukhuset Solna ( Site 0802), Stockholm, Stockholms Lan

Blod och Tumorssjukdomar. Akademiska sjukhuset ( Site 0801), Uppsala, Uppsala Lan

Norrlands Universitetssjukhus ( Site 0800), Umea, Vasterbottens Lan

Sahlgrenska Universitetssjukhuset-Department of Oncology CTU Clinical Trial Unit ( Site 0803), Gothenburg, Vastra Gotalands Lan

University Hospital Basel ( Site 0752), Basel, Basel-Stadt

Hôpitaux Universitaires de Genève (HUG) ( Site 0753), Genève, Geneve

Universitaetsspital Zuerich ( Site 0750), Zürich-Flughafen, Zurich

Kaohsiung Chang Gung Memorial Hospital ( Site 3203), Kaohsiung, Not set

China Medical University Hospital ( Site 3204), Taichung, Not set

National Cheng Kung University Hospital ( Site 3201), Tainan, Not set

National Taiwan University Hospital ( Site 3200), Taipei, Not set

Mackay Memorial Hospital ( Site 3205), Taipei, Not set

Taipei Veterans General Hospital ( Site 3202), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch ( Site 3206), Taoyuan, Not set

Chulalongkorn University ( Site 2363), Bangkok, Krung Thep Maha Nakhon

Ramathibodi Hospital ( Site 2364), Bangkok, Krung Thep Maha Nakhon

Faculty of Medicine Siriraj Hospital ( Site 2365), Bangkok, Krung Thep Maha Nakhon

Acibadem Altunizade Hospital-Oncology ( Site 1317), Üsküdar /Istanbul, Istanbul

Acibadem Adana Hospital-Pediatric Hematology-Oncology ( Site 1312), Adana, Not set

Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1307), Adana, Not set

Ankara University Hospital Cebeci ( Site 1306), Ankara, Not set

Hacettepe Universitesi-oncology hospital ( Site 1304), Ankara, Not set

Ankara City Hospital-Medical Oncology ( Site 1311), Ankara, Not set

Baskent Universitesi Ankara Hastanesi ( Site 1303), Ankara, Not set

Memorial Antalya Hospital-Oncology ( Site 1315), Antalya, Not set

Trakya Universitesi Tip Fakultesi ( Site 1301), Edirne, Not set

Bezmialem Vakf Üniversitesi-Oncology ( Site 1308), Istanbul, Not set

Istanbul University Capa Campus ( Site 1314), Istanbul, Not set

Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1302), Istanbul, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1316), Istanbul, Not set

Marmara Universitesi Pendik Egitim Arastirma Hastanesi-Medical Oncology ( Site 1305), Istanbul, Not set

Ege Universitesi Tip Fakultesi Hastanesi ( Site 1300), Izmir, Not set

I.E.U. Medical Point Hastanesi-Oncology ( Site 1310), Izmir, Not set

Kocaeli Üniversitesi ( Site 1313), Kocaeli, Not set

Inonu Universitesi ( Site 1309), Malatya, Not set

Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council ( Site 3650), Dnipro, Dnipropetrovska Oblast

MI Kryvyi Rih Oncology Dispensary of Dnipropetrovsk Regional-Chemotherapy department ( Site 3657), Kryvyi Rih, Dnipropetrovska Oblast

Communal Non-Commercial Enterprise "Prykarpatski Clinical Oncological Center" of Ivano-Frankivsk Reg, Ivano-Frankivsk, Ivano-Frankivska Oblast

MNPE Regional Center of Oncology ( Site 3665), Kharkiv, Kharkivska Oblast

Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 3656), Kropyvnytskyi, Kirovohradska Oblast

National Cancer Institute-Department of Minimally Invasive and Endoscopic Surgery, Interventional R, Kyiv, Kyivska Oblast

Municipal non-profit enterprise "Kyiv City Clinical Oncology Center" of executive body of Kyiv City, Kyiv, Kyivska Oblast

Municipal institution of Lviv regional council Lviv Oncology-Chemotherapy ( Site 3653), Lviv, Lvivska Oblast

Odessa Regional Oncology Center ( Site 3655), Odessa, Odeska Oblast

Sumy regional clinical oncological dispensary-Oncothoracic department ( Site 3661), Sumy, Sumska Oblast

Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council", Vinnytsia, Vinnytska Oblast

Transcarpathian Regional Clinical Oncology Center-Chemotherapy dept. ( Site 3652), Uzhhorod, Zakarpatska Oblast

Municipal non-profit enterprise "Zaporizhzhia Regional Antitumor Center" Zaporizhzhya Regional Counc, Zaporizhia, Zaporizka Oblast

Aberdeen Royal Infirmary-Department of Oncology ( Site 0521), Aberdeen, Aberdeen City

Western General Hospital ( Site 0502), Edinburgh, Edinburgh, City Of

The Christie ( Site 0516), Manchester, England

Weston Park Hospital ( Site 0519), Sheffield, England

Mid Essex Hospitals Service Trust. Broomfield Hospital ( Site 0503), Broomfield, Essex

The Beatson West of Scotland Cancer Centre ( Site 0506), Glasgow, Glasgow City

Royal Preston Hospital ( Site 0518), Preston, Lancashire

Barts Health NHS Trust ( Site 0512), London, London, City Of

University College London Hospital-Cancer Clinical Trials Unit ( Site 0520), London, London, City Of

Royal Free Hospital ( Site 0507), London, London, City Of

Royal Marsden Hospital ( Site 0505), London, London, City Of

Sarah Cannon Research UK ( Site 0504), London, London, City Of

Belfast City Hospital ( Site 0508), Belfast, Northern Ireland

Nottingham University Hospitals NHS Trust ( Site 0510), Nottingham, Nottinghamshire

St James University Hospital ( Site 0509), Leeds, Not set

The Royal Marsden NHS Foundation Trust. ( Site 0513), Sutton, Not set

New Cross Hospital-Department of Oncology ( Site 0517), Wolverhampton, Not set

Conditions: Solid Tumors, Hematologic Malignancies

Learn More ›

Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

NCT04589845

Recruiting

TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified combinations in participants with unresectable, locally advanced or metastatic solid tumors determined to harbor specific oncogenic genomic alterations or who are tumor mutational burden (TMB)-high as identified by a validated next-generation sequencing (NGS) assay. Participants with solid tumors... Read More

Gender:

All

Ages:

All

Trial Updated:

05/09/2024

Locations: Southern Cancer Center, Daphne, Alabama +167 locations

Southern Cancer Center, Daphne, Alabama

Western Regional Medical Center at Cancer Treatment Centers of America, Goodyear, Arizona

City of Hope National Medical Center, Duarte, California

Kaiser Permanente Los Angeles; Clinic/Infusion -LA, Los Angeles, California

USC Norris Cancer Center, Los Angeles, California

Hoag Memorial Hospital, Newport Beach, California

UC Davis Comprehensive Cancer Center, Sacramento, California

University of California at San Francisco, San Francisco, California

Sarcoma Oncology Center, Santa Monica, California

Children's Hospital Colorado; Center For Cancer/Blood Disorder, Aurora, Colorado

Christiana Care Health Srvcs; Helen F Graham Can Center, Newark, Delaware

University of Florida, Gainesville, Florida

Miami Cancer Institute of Baptist Health, Inc., Miami, Florida

Ocala Oncology Center, Ocala, Florida

University Cancer & Blood Center, LLC; Research, Athens, Georgia

St. Alphonsus, Boise, Idaho

Midwestern Regional Med Center, Zion, Illinois

Horizon Oncology Research, Inc., Lafayette, Indiana

New England Cancer Specialists, Scarborough, Maine

Maryland Hematology & Oncology. P.A., Silver Spring, Maryland

St. Joseph Mercy Hospital, Ann Arbor, Michigan

Henry Ford Health System, Detroit, Michigan

University of Minnesota, Minneapolis, Minnesota

Metro-Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota

Washington University, Saint Louis, Missouri

Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana, Billings, Montana

Nebraska Methodist Hospital; Cancer Center, Omaha, Nebraska

Comprehensive Cancer Centers of Nevada - Eastern Avenue, Las Vegas, Nevada

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

University of New Mexico; Comprehensive Cancer Center, Albuquerque, New Mexico

Montefiore Einstein Center for Cancer Care, Bronx, New York

Eastchester Center for Cancer Care, Bronx, New York

New York Cancer and Blood Specialists - Setauket Medical Oncology, East Setauket, New York

National Translational Research Group, New York, New York

Icahn School of Medicine at Mount Sinai, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Levine Cancer Institute, Charlotte, North Carolina

Barrett Cancer Center, Cincinnati, Ohio

Oncology Hematology Care Inc, Cincinnati, Ohio

Providence Portland Medical Center, Portland, Oregon

Consultants in Medical Oncology and Hematology, Broomall, Pennsylvania

Alliance Cancer Specialists, Horsham, Pennsylvania

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Cancer Treatment Centers of America; Eastern Regional Medical Center, Philadelphia, Pennsylvania

PRISMA Health - Greenville, Greenville, South Carolina

The West Clinic; West Cancer Center, Germantown, Tennessee

St. Jude Children'S Research Hospital, Memphis, Tennessee

Texas Onc-Central Austin CA Ct, Austin, Texas

Mary Crowley Medical Research Center, Dallas, Texas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

Cook Childrens Medical Center, Fort Worth, Texas

The University of Texas MD Anderson Cancer Center, Houston, Texas

Texas Oncology- Northeast Texas, Tyler, Texas

Virginia Cancer Specialists - Leesburg, Leesburg, Virginia

Northwest Medical Specialties, PLLC; Research Department, Tacoma, Washington

Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin

Kinghorn Cancer Centre; St Vincents Hospital, Darlinghurst, New South Wales

Sydney Children's Hospital, Randwick, New South Wales

Royal Darwin Hospital; Alan Walker Cancer Centre, Tiwi, Northern Territory

Princess Alexandra Hospital, Woolloongabba, Queensland

Peter MacCallum Cancer Centre; Medical Oncology, Melbourne, Victoria

Royal Children's Hospital, Parkville, Victoria

Cliniques Universitaires St-Luc, Bruxelles, Not set

GHdC Site Notre Dame, Charleroi, Not set

UZ Antwerpen, Edegem, Not set

UZ Gent, Gent, Not set

UZ Leuven Gasthuisberg, Leuven, Not set

Hospital Moinhos de Vento, Porto Alegre, RS

Hospital Sírio-Libanês, Sao Paulo, SP

Hospital A. C. Camargo; Oncologia, Sao Paulo, SP

Clínica Onco Star - Rede D'Or, Sao Paulo, SP

BC Cancer ? Vancouver, Vancouver, British Columbia

London Health Sciences Centre · Victoria Hospital; Department of Medicine, London, Ontario

The Ottawa Hospital - General Campus, Ottawa, Ontario

The Hospital for Sick Children, Toronto, Ontario

Princess Margaret Cancer Center, Toronto, Ontario

McGill University Health Center, Montreal, Quebec

Beijing Children's Hospital, Capital Medical University; Oncological Surgery Department, Beijing City, Not set

Beijing Cancer Hospital, Beijing, Not set

The First Hospital of Jilin University, Changchun City, Not set

Jilin Cancer Hospital, Changchun, Not set

West China Hospital - Sichuan University, Chengdu City, Not set

Zhongshan Hospital Fudan Unvierstiy, Shanghai City, Not set

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Not set

Shanghai East Hospital, Shanghai, Not set

Tianjin Cancer Hospital, Tianjin, Not set

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Not set

Aarhus Universitetshospital; Kræftafdelingen, Aarhus N, Not set

Rigshospitalet; Onkologisk Klinik, København Ø, Not set

Institut Bergonie; Oncologie, Bordeaux, Not set

Centre Oscar Lambret; Service de Pediatrie, Lille, Not set

CENTRE LEON BERARD; Département d?Hématologie et d?Oncologie, Lyon, Not set

Hopital de la Timone, Marseille, Not set

Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, Not set

Institut de Cancerologie Gustave-Roussy (IGR), Villejuif, Not set

Uniklinik Essen, Essen, Not set

Universitätsklinikum Freiburg Medizinische Klinik Innere Medizin I, Freiburg, Not set

Georg-August-Uniklinik ; Zentrum Innere Medizin Abt. Hämatologie & Onkologie, Göttingen, Not set

Universitätsklinikum Hamburg-Eppendorf Onkologisches Zentrum Medizinische Klinik II, Hamburg, Not set

Medizinische Hochschule Zentrum Innere Medizin Abt.Gastroenterologie, Endokrinologie und Hepatologie, Hannover, Not set

SLK-Kliniken Heilbronn GmbH; Klinik für Innere Medizin III; Schwerpunkt Häma./Onko./Palliativm., Heilbronn, Not set

Praxis für Hämatologie, Onkologie und Palliativmedizin, Mönchengladbach, Not set

Klinikum der Universität München, Campus Großhadern; Medizinische Klinik und Poliklinik III, München, Not set

Universtitätsklinikum Ulm; Klinik für Innere Medizin III, Ulm, Not set

Uniklinikum, Comprehensive Cancer Center Mainfranken; Interdisziplinäres Studienzentrum mit ECTU, Würzburg, Not set

Hong Kong Children's Hospital, Hong Kong, Not set

Prince of Wales Hospital; Department of Clinical Onocology, Shatin, Not set

Rambam Health Care Campus; Oncology, Haifa, Not set

Hadassah University Hospital - Ein Kerem, Jerusalem, Not set

Rabin MC; Davidof Center - Oncology Institute, Petach Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

Sourasky / Ichilov Hospital; Dept. of Oncology, Tel Aviv, Not set

Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania

Ospedale Pediatrico Bambino Gesù - IRCCS; Dipartimento di Onco-Ematologia Pediatrica, Roma, Lazio

Policlinico Universitario Agostino Gemelli IRCCS; UOS Fase 1, Roma, Lazio

Asst Degli Spedali Civili Di Brescia, Brescia, Lombardia

Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1, Milano, Lombardia

Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica, Milano, Lombardia

Dipartimento di Scienze Pediatriche Adolescenza; Osp. Infantile Regina Margherita, Torino, Piemonte

Azienda Ospedaliera Meyer; Centro di Eccellenza di Oncologia ed Ematologia Pediatrica, Firenze, Toscana

Azienda Ospedaliera Universitaria Senese, U.O.C. Immunoterapia Oncologica, Siena, Toscana

National Cancer Center Hospital East, Chiba, Not set

Kindai University Hospital, Osaka, Not set

National Cancer Center Hospital, Tokyo, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Seoul National University Hospital- Adult Site, Seoul, Not set

Seoul National University Hospital- Pediatric Site, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center- Adult Site, Seoul, Not set

Samsung Medical Center- Pediatric Site, Seoul, Not set

Prinses Maxima Centrum, Utrecht, Not set

Auckland City Hospital, Cancer and Blood Research, Auckland, Not set

Christchurch Hospital; Dept of Oncology, Christchurch, Not set

Uniwersyteckie Centrum Kliniczne, Klinika Onkologii i Radioterapii, Gdansk, Not set

Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad; Klinika Nowot.Pluca i Klatki Piers, Warszawa, Not set

IPO do Porto; Servico de Oncologia Medica, Porto, Not set

PanOncology Trials; Hospital Oncológico, Puerto Rico Medical Center, San Juan, Not set

National University Hospital; National University Cancer Institute, Singapore (NCIS), Singapore, Not set

National Cancer Centre; Medical Oncology, Singapore, Not set

Medical Oncology Centre of Rosebank; Oncology, Johannesburg, Not set

Hospital Sant Joan De Deu, Esplugues De Llobregas, Barcelona

Hospital Univ Vall d'Hebron; Servicio de Oncologia, Sant Andreu de La Barca, Barcelona

Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Not set

Hospital Infantil Universitario Nino Jesus, Madrid, Not set

Clinica Universidad de Navarra Madrid; Servicio de Oncología, Madrid, Not set

START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid, Not set

Hospital Universitario La Paz; Servicio de Oncologia, Madrid, Not set

START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid, Not set

Hospital Universitario la Fe; Servicio de Oncologia, Valencia, Not set

Universitätsspital Basel (USB), Basel, Not set

Ospedale Regionale di Bellinzona Medizin Onkologie, Bellinzona, Not set

Inselspital, Klinik und Poliklinik für Medizinische Onkologie, Bern, Not set

Unversitätsspital Zürich, Zürich, Not set

Taichung Veterans General Hospital; Division of Hema-Oncology, Taichung, Not set

National Cheng Kung University Hospital; Oncology, Tainan, Not set

Taipei Veterans General Hospital; Department of Oncology, Taipei City, Not set

Chang Gung Memorial Hospital-Linkou; Dept of Oncology, Taoyuan County, Not set

National Taiwan University Hospital; Oncology, Zhongzheng Dist., Not set

Beatson West of Scotland Cancer Centre, Glasgow, Not set

University College London Hospital, London, Not set

Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, Not set

Royal Manchester Children?s Hospital, Manchester, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Royal Marsden Hospital (Sutton), Sutton, Not set

Conditions: Solid Tumors

Learn More ›

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

NCT05315700

Recruiting

The purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of ORIC-114 as a Single Agent or in Combination with Chemotherapy when administered to patients with advanced solid tumors harboring an EGFR or HER2 alteration.

Gender:

All

Ages:

18 years and above

Trial Updated:

05/08/2024

Locations: City of Hope, Duarte, California +33 locations

City of Hope, Duarte, California

City of Hope, Huntington Beach, California

City of Hope, Irvine, California

City of Hope, Long Beach, California

University of California, San Francisco, San Francisco, California

Yale Cancer Center, New Haven, Connecticut

Georgetown University, Washington, District of Columbia

Mayo Clinic, Jacksonville, Florida

Moffitt Cancer Center, Tampa, Florida

Northwestern University, Chicago, Illinois

Dana Farber Cancer Institute, Boston, Massachusetts

Mayo Clinic, Rochester, Minnesota

NYU Langone Health Perlmutter Cancer Center, New York, New York

Duke Cancer Institute, Durham, North Carolina

University of Pennsylvania, Philadelphia, Pennsylvania

Spartanburg Regional Healthcare System, Spartanburg, South Carolina

Next Oncology, Fairfax, Virginia

Chris O'Brien Lifehouse, Camperdown, Not set

Peter MacCallum Cancer Centre, Melbourne, Not set

One Clinical Research, Hollywood Medical Centre, Nedlands, Not set

Sydney Adventist Health, Sydney, Not set

Princess Margaret Cancer Centre, Toronto, Ontario

The Chinese University of Hong Kong, Shatin, Not set

Chungbuk University Hospital, Cheongju-si, Not set

National Cancer Center, Goyang-si, Not set

Catholic University of Korea, St, Vincent Hospital, Gyeonggi-do, Not set

Gachon University Hospital, Incheon, Not set

Seoul National Bundang Hospital, Seongnam-si, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Medical University of Gdańsk, Gdańsk, Not set

National Taiwan University Hospital, Taipei, Not set

The Christie NHS Foundation Trust, Manchester, England

Conditions: Solid Tumors

Learn More ›

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

NCT05325866

Recruiting

The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

Gender:

All

Ages:

Between 18 years and 99 years

Trial Updated:

05/08/2024

Locations: City of Hope National Medical Center, Duarte, California +109 locations

City of Hope National Medical Center, Duarte, California

University of California Irvine, Orange, California

Rocky Mountain Cancer Centers, Aurora, Colorado

US Oncology Regulatory Affairs Corporate Office, Denver, Colorado

US Oncology Research Investigational Products Center, Denver, Colorado

Community Health Network MD Anderson Cancer Center - North, Indianapolis, Indiana

Henry Ford Hospital, Detroit, Michigan

Texas Oncology - Dallas Fort Worth, Dallas, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Texas Oncology Northeast Texas, Tyler, Texas

Instituto Alexander Fleming, Capital Federal, Buenos Aires

Hospital Aleman, Ciudad Autonoma de Buenos Aires, Buenos Aires

Fundacion Cenit Para La Investigacion, Ciudad Autonoma de Buenos Aires, Buenos Aires

Hospital Italiano de La Plata, La Plata, Buenos Aires

Sociedad de Beneficencia Hospital Italiano, Cordoba, Córdoba

Fundacion Medica de Rio Negro y Neuquen, Cipolletti, Río Negro

Centro Oncologico Korben, Buenos Aires, Not set

Liverpool Hospital, Liverpool, New South Wales

Prince of Wales Hospital, Randwick, New South Wales

Wollongong Hospital, Wollongong, New South Wales

Toowoomba Hospital, Toowoomba, Queensland

Cabrini Hospital, Malvern, Victoria

St John of God Murdoch Hospital, Murdoch, Western Australia

Medizinische Universitaet Graz, Graz, Not set

Landeskrankenhaus Salzburg, Salzburg, Not set

Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Not set

Grand Hopital de Charleroi, Charleroi, Not set

Universitair Ziekenhuis Antwerpen, Edegem, Not set

Universitair Ziekenhuis Gent, Gent, Not set

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Not set

Hospital das Clinicas da Ufmg, Belo Horizonte, Minas Gerais

Centro de Oncologia Mackenzie, Curitiba, Paraná

Associacao Hospitalar Moinhos de Vento, Porto Alegre, Rio Grande Do Sul

Instituto do Cancer Arnaldo Vieira de Carvalho, Sao Paulo, São Paulo

Beneficencia Portuguesa de Sao Paulo, Sao Paulo, São Paulo

Oncologia Rede D Or, Sao Paulo, São Paulo

Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, Not set

Multiprofile Hospital for Active Treatment Central Onco Hospital OOD, Plovdiv, Not set

Complex Oncology Center Plovdiv EOOD, Plovdiv, Not set

Military Medical Academy Multiprofile Hospital for Active Treatment - Sofia, Sofia, Not set

Cross Cancer Institute, Edmonton, Alberta

The Ottawa Hospital Cancer Centre, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Masarykuv onkologicky ustav, Brno, Not set

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set

Fakultni nemocnice Olomouc, Olomouc, Not set

Fakultni nemocnice Kralovske Vinohrady, Praha 10, Not set

Rigshospitalet, Kobenhavn O, Not set

Docrates Syopasairaala, Helsinki, Not set

Tampere University Hospital, Tampere, Not set

Institut de Cancerologie de l Ouest Rene Gauducheau, Angers Cedex 02, Not set

Centre Hospitalier Régional Universitaire de Besançon, Hôpital Jean Minjoz, Besancon cedex, Not set

Centre Oscar Lambret, Lille Cedex, Not set

Institut Paoli Calmettes, Marseille Cedex 09, Not set

Institut regional du Cancer Montpellier, Montpellier Cedex 5, Not set

Centre Hospitalier Lyon Sud, Pierre-Benite, Not set

Institut Claudius Regaud, Toulouse cedex 9, Not set

Gustave Roussy, Villejuif, Not set

Sotiria General Hospital, Athens, Not set

Alexandra Hospital, Athens, Not set

Metropolitan General, Athens, Not set

University Hospital of Heraklion, Heraklion - Crete, Not set

European Interbalkan Medical Center, Thessaloniki, Not set

Semmelweis Egyetem, Budapest, Not set

Orszagos Onkologiai Intezet, Budapest, Not set

Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz Nyiregyhazi Josa Andras Tagkorhaz, Nyiregyhaza, Not set

Jasz-Nagykun-Szolnok Varmegyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Not set

Rambam Medical Center, Haifa, Not set

Hadassah Ein-Kerem Medical Center, Jerusalem, Not set

Rabin Medical Center, Petah Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set

Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia, Foggia, Not set

Azienda Unità Locale Socio Sanitaria 3 Presidio Ospedaliero di Mirano, Mirano, Not set

Ospedale del Mare, Napoli, Not set

Azienda Ospedaliera Universitaria Pisana Ospedale Santa Chiara, Pisa, Not set

Aichi Cancer Center, Nagoya-shi, Aichi

National Cancer Center Hospital East, Kashiwa-shi, Chiba

Kindai University Hospital, Osakasayama-shi, Osaka

National Cancer Center Hospital, Chuo-ku, Tokyo

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Asan Medical Center, Seoul, Not set

Investigación Onco Farmacéutica S de RL de CV, La Paz, Baja California Sur

Centro de Infusion e Investigacion Oncologia de Saltillo, Saltillo, Coahuila

Investigacion Biomedica para el Desarrollo de Farmacos, Ciudad de Mexico, Distrito Federal

Health Pharma Professional Research SA de CV, Mexico City, Distrito Federal

Christus Muguerza Clinica Vidriera, Monterrey, Nuevo León

Universitair Medisch Centrum Groningen, Groningen, Not set

Radboud Universitair Medisch Centrum, Nijmegen, Not set

Pratia Mcm Krakow, Krakow, Not set

Instytut Centrum Zdrowia Matki Polki, Lodz, Not set

Ars Medical Spzoo, Pila, Not set

Mazowiecki Szpital Wojewodzki im Sw Jana Pawla II w Siedlcach spzoo, Siedlce, Not set

Centrum Medyczne Pratia Poznan, Skorzewo, Not set

Unidade Local de Saude de Lisboa Ocidental, EPE - Hospital Sao Francisco Xavier, Lisboa, Not set

Hospital da Luz, SA, Lisboa, Not set

Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria, Lisboa, Not set

Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj Napoca, Not set

Centrul de Oncologie Sf Nectarie SRL, Craiova, Not set

Institutul Regional de Oncologie Iasi, Iasi, Not set

SC Oncomed SRL, Timisoara, Not set

Hospital Clinico Universitario Virgen de la Victoria, Malaga, Andalucía

Hospital Clinico Universitario de Santiago, Santiago de Compostela, Galicia

Kantonsspital Graubuenden, Chur, Not set

Hopitaux Universitaires de Geneve, Geneve, Not set

Christie Hospital, Manchester, Not set

Weston Park Hospital, Sheffield, Not set

Conditions: Solid Tumors

Learn More ›

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

NCT03175224

Recruiting

To assess: efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET fusion, primary CNS tumors harboring MET alterations, solid tumors harboring wild-type MET with overexpression of HGF and MET efficacy of APL-101 as an add-on therapy to EGFR inhibitor for the treatment of NSCLC harboring EGFR activating mutations and developed acquired resistanc... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

05/08/2024

Locations: Loma Linda University Medical Center, Loma Linda, California +90 locations

Loma Linda University Medical Center, Loma Linda, California

University of Southern California / Norris Comprehensive Cancer Center, Los Angeles, California

Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California

Kaiser Permanente - CA, Riverside, California

UCSF - Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Providence Medical Foundation, Santa Monica, California

Providence St. Joseph Health, Santa Rosa, California

Kaiser Permanente - Vallejo, Vallejo, California

Christiana Hospital, Newark, Delaware

Florida Cancer Specialists - South, Fort Myers, Florida

Miami Cancer Institute, Miami, Florida

Florida Cancer Specialists - North, Saint Petersburg, Florida

Florida Cancer Specialists, Tallahassee, Florida

Moffitt, Tampa, Florida

Florida Cancer Specialists, West Palm Beach, Florida

Maryland Oncology Hematology, Silver Spring, Maryland

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Mayo Clinic, Rochester, Minnesota

HealthPartners Cancer Research Center, Saint Louis Park, Minnesota

Washington University School of Medicine, Saint Louis, Missouri

University of North Carolina, Chapel Hill, North Carolina

Wake Forest University Health Sciences, Winston-Salem, North Carolina

The Ohio State University (OSU), Columbus, Ohio

Ohio Health Research Institute, Columbus, Ohio

Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania

St. Francis Cancer Center, Greenville, South Carolina

Sarah Cannon and HCA Research Institute, Nashville, Tennessee

The Don & Sybil Harrington Cancer Center, Amarillo, Texas

West Virginia University Cancer Institute, Morgantown, West Virginia

University of Wisconsin, Madison, Wisconsin

Flinders Medical Centre, Bedford Park, South Australia

Border Medical Oncology, Albury, Not set

Peninsula and Southeast Oncology, Frankston, Not set

St Vincents Hospital Melbourne, Melbourne, Not set

Sir Charles Gairdner Hospital, Nedlands, Not set

Calvary Central Districts Hospita, North Adelaide, Not set

Lady Davis Institute for Medical Research Jewish General Hospital, Montreal, Quebec

Cross Cancer Institute, Edmonton, Not set

McGill University Health Center - Research Institute, Montréal, Not set

Princess Margaret Hospital, Toronto, Not set

Cancer Care Manitoba, Winnipeg, Not set

Tampere University Hospital, Tampere, Not set

CHRU de Brest - Hôpital Morvan, Brest, Not set

CHRU de Lille, Lille, Not set

Centre Leon Berard, Lyon, Not set

Centre d'Essais Precoces en Cancerologie de Marseille, Marseille, Not set

Hopital Bichat - Claude Bernard - AP-HP, Paris, Not set

CHU Rennes - Hopital Pontchaillou, Rennes, Not set

Gustave Roussy, Villejuif, Not set

Orszagos Koranyi Pulmonologiai Intezet, Budapest, Not set

Szent Borbala Korhaz, Tatabanya, Not set

Torokbalinti Tudogyogyintezet, Torokbalint, Not set

Azienda Ospedaliero-Universitaria delle Marche, Ancona, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola, Bologna, Not set

Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco - Presidio Ospedaliero G. Rodolico, Catania, Not set

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Not set

Istituto Europeo di Oncologia, Milano, Not set

IRCCS Ospedale San Raffaele, Milan, Not set

Istituto Oncologico Veneto-I.R.C.C.S. - Ospedale Busonera, Padova, Not set

AOU Citta della Salute e della Scienza di Torino - Ospedale le Molinette, Torino, Not set

PanOncology Trials, LLC, Rio Piedras, Not set

Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Not set

JSC Group of companies Medsi, Otradnoye, Not set

Private Medical Institution Euromedservice, Saint Petersburg, Not set

Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncology), Saint Petersburg, Not set

Ogarev Mordovia State University, Saransk, Not set

JSC Current Medical Technologies, St. Petersburg, Not set

Volgograd Regional Clinical Oncology Dispensary, Volgograd, Not set

National Cancer Centre Singapore, Singapore, Not set

Oncocare Cancer Centre, Singapore, Not set

Tan Tock Seng Hospital, Singapore, Not set

Hospital Germans Trias i Pujol, Badalona, Not set

Hospital Clinic Barcelona, Barcelona, Not set

Hospital del Mar, Barcelona, Not set

Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Not set

Hospital Universitario Ramon y Cajal, Madrid, Not set

Hospital Universitario Central de Asturias, Oviedo, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Instituto Valenciano de Oncologia, Valencia, Not set

Taichung Veterans General Hospital, Taichung, Not set

Chi-Mei Hospital - Liouying Branch, Tainan, Not set

National Taiwan University Hospital, Taipei City, Not set

Linkou Chang Gung Memorial Hospital (CGMHLK), Taoyuan City, Not set

Imperial College Healthcare NHS Trust, London, Not set

University College London Hospital, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Royal Marsden Hospital - Surrey, Surrey Quays, Not set

Conditions: Advanced Cancer, Renal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC, Lung Cancer, Brain Tumor, Glioblastoma Multiforme, Solid Tumors, EGFR Gene Mutation, MET Amplification, HGF, Thyroid Cancer, Pancreatic Cancer, Colon Cancer, MET Alteration, MET Fusion, Exon 14 Skipping

Learn More ›

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT04250155

Recruiting

This study will evaluate the safety, tolerability, pharmacokinetics, and activity of XmAb24306 alone or in combination with a checkpoint inhibitor treatment in participants with locally advanced or metastatic solid tumors.

Gender:

All

Ages:

18 years and above

Trial Updated:

05/06/2024

Locations: Honor Health Research Institute, Scottsdale, Arizona +30 locations

Honor Health Research Institute, Scottsdale, Arizona

City of Hope Comprehensive Cancer Center, Duarte, California

Stanford Health Centre - Palo Alto, Palo Alto, California

UCSF Helen Diller Family CCC, San Francisco, California

University of California San Francisco Cancer Center, San Francisco, California

Yale University, New Haven, Connecticut

The University of Oklahoma Health Sciences Center; Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma

SCRI Oncology Partners, Nashville, Tennessee

Virginia Cancer Specialists (Fairfax) - USOR, Fairfax, Virginia

Peter Mac Callum Cancer Center, East Melbourne, Victoria

GasthuisZusters Antwerpen, Wilrijk, Not set

Hospital de Clinicas de Porto Alegre HCPA PPDS, Porto Alegre, PA

Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, SP

Princess Margaret Hospital; Clinical Trials Pharmacy, Toronto, Ontario

Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec

Istituto Nazionale Dei Tumori; Dipartimento Chirurgia Generale - Unita' Trapianti Fegato, Milano, Lombardia

Istituto Europeo Di Oncologia, Milano, Lombardia

Istituto Clinico Humanitas, Rozzano (MI), Lombardia

Seoul National University Bundang Hospital; Pharmacy, Seongnam-si, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System - PPDS, Seoul, Not set

Asan Medical Center - PPDS, Seoul, Not set

Samsung Medical Center - PPDS, Seoul, Not set

Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, Not set

VU Medisch Centrum, Amsterdam, Not set

Universitair Medisch Centrum Groningen, Groningen, Not set

Clinica Universitaria de Navarra, Pamplona, Navarra

C.H. Regional Reina Sofia - PPDS, Cordoba, Not set

Clinica Universidad de Navarra-Madrid, Madrid, Not set

START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Conditions: Solid Tumors

Learn More ›

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

NCT03313778

Recruiting

The purpose of this study is to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone and in combination in participants with solid tumors.

Gender:

All

Ages:

18 years and above

Trial Updated:

05/02/2024

Locations: University of Arizona, Tucson, Arizona +10 locations

Conditions: Solid Tumors

Learn More ›

Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors

NCT02379416

Recruiting

Background: - Researchers want to find better ways to treat cancer. One drug that treats cancer is paclitaxel. Sometimes proteins block that drug from working. Researchers want to see if another drug, nilotinib, helps paclitaxel work better. Objective: - To test the safety of nilotinib plus paclitaxel and find out what doses of the drugs can be given safely to people. Eligibility: - Adults at least 18 years old with advanced cancer that has progressed after receiving standard treatment, or... Read More

Gender:

All

Ages:

Between 12 years and 120 years

Trial Updated:

05/02/2024

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Solid Tumors

Learn More ›

1 - 12 of 48